Home / Locations / Bioluminux Clinical Research Milton Keynes
Bioluminux Clinical Research Milton Keynes
About This Site
Our Milton Keynes site serves as Bioluminux’s UK headquarters and a key center for clinical research delivery, supporting Phase 2–4 industry-sponsored trials across vaccines and infectious diseases, respiratory medicine, cardiovascular disease, metabolic disorders, dermatology, CNS and mental health, and other therapeutic areas.
Experienced industry investigators, physician leaders, and clinical research professionals lead the site, including investigators with extensive pharmaceutical medicine and Chief Investigator experience. This depth of expertise supports complex studies requiring strong medical oversight, participant safety, regulatory compliance, and high-quality data delivery.
With dedicated research infrastructure, established operational systems, and access to diverse patient populations across Milton Keynes and surrounding communities, the site provides sponsors and CROs with experienced study leadership, efficient trial execution, and dependable enrollment performance.
Research Leadership
Oluwaseun Ojo BSc, APDPM, MSc(c)
Site Manager
Specialty:
Dr Ashish Shrestha MBBS, APDPM, MSc, MFPM
Global Lead for Clinical Research & Lead Physician
Specialty:
Dr Babatunde Oyesile MBChB, MRCS, DPM, MFPM, MBA
Principal Investigator
Specialty:
Dr Adeogo Olusan MD, MSc, MRCP (UK), BSE, CCT - Cardiology
Principal Investigator/Interventional Cardiologist
Specialty:
Dr Kayode Timothy MD, MRCPsych, APGDPM, MSc, MFPM
Principal Investigator/Psychiatrist
Specialty:
Site Facilities & Amenities
Recruiting Studies At This Location
COPD and Common Colds Research Study
To investigate whether an antiviral medicine can reduce symptoms and COPD flare-ups caused by rhinovirus, a common cold virus.
Hypertension Study
To evaluate whether the investigational treatment reduces the risk of major cardiovascular events in adults with uncontrolled hypertension.
Seasonal Flu Prevention Research Study
To investigate whether an investigational medicine can prevent flu illness in people at higher risk of complications.